Fluetizolam 1 MG Pellets
Fluetizolam 1 MG Pellets Price range: € 12,95 through € 197,96
Back to products
Isopropylphenidate (IPPH) 25 MG Pellets
Isopropylphenidate (IPPH) 25 MG Pellets Price range: € 13,50 through € 459,95

IDRA-21 10MG Pellets

Price range: € 13,50 through € 398,58

Product Name: IDRA-21 10MG Pellets
Catalog #: ALC-IDRA-10
Purity: >97% (Verified by HPLC)
Quantity: Available in 10, 20, 50, 100, 250, or 500 pellets

Physical and Chemical Properties:

  • Appearance: Round, uniform white to off-white unmarked pellets

  • Active Ingredient: IDRA-21 (7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide)

  • Solubility: Freely soluble in DMSO and ethanol; sparingly soluble in water

  • Molecular Formula: C₈H₉ClN₂O₂S

  • Molecular Weight: 232.6 g/mol

  • CAS Number: 22503-72-6

  • Melting Point: 278–282°C

  • Storage: Cool, dry, away from light (15–25°C) in sealed original container

  • Stability: >24 months under recommended conditions

SKU: N/A Category: Tags: ,
Description

Buy IDRA-21 10MG Pellets Research Chemical Online – USA, Europe & Worldwide

Welcome to RChems EU, a globally trusted supplier of high-purity research chemicals serving academic, pharmaceutical, and neuroscience laboratories across five continents. Our IDRA-21 10MG Pellets offer researchers a standardized, analytically verified tool for exploring AMPA receptor positive allosteric modulation and cognitive enhancement mechanisms.

IDRA-21 (7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide) is a potent, orally active, and centrally penetrant positive allosteric modulator (PAM) of the AMPA-type glutamate receptor. It belongs to the ampakine class of compounds—a group of synthetic molecules developed specifically for their potential cognitive-enhancing properties. IDRA-21 enhances AMPA receptor-mediated synaptic transmission by slowing receptor deactivation and desensitization, thereby increasing the amplitude and duration of excitatory postsynaptic currents (EPSCs). AMPA receptors are a subtype of glutamate receptor critically involved in synaptic plasticity—the ability of synapses to change in strength—which is fundamental to learning, memory consolidation, and adaptive behavior.

When you buy IDRA-21 10MG pellets from RChems EU, you receive a rigorously synthesized, analytically verified research compound at >97% purity. Each pellet delivers a precise 10mg dose, eliminating weighing variability and minimizing researcher exposure during handling. Whether your laboratory is located in the USA, Germany, Japan, Australia, or Brazil, our worldwide logistics network ensures rapid, discreet delivery directly to your institutional address.

Key Features & Benefits

  • High Verified Purity (>97%): Every production batch undergoes independent testing using HPLC-DAD. Impurity profiles are carefully controlled, ensuring reproducible results in electrophysiology, synaptic plasticity, and behavioral pharmacology assays.
  • Standardized 10mg Pellet Format: Pre-dosed, homogeneous pellets eliminate the need for analytical weighing, reducing both preparation time and potential gravimetric error. Ideal for dissolution testing, calibration curve generation, and repeated-dose study designs.
  • Discreet & Secure Packaging: Plain, unmarked outer boxes with zero chemical identifiers. Vacuum-sealed inner pouches protect against moisture, oxidation, and tampering. No mention of “IDRA-21,” “ampakine,” or “research chemical” on any external shipping label or customs declaration.
  • Fast Worldwide Delivery: Strategic dispatch hubs in the European Union and United States. Typical transit: 3–7 business days to USA, UK, and Canada; 5–12 days to Australia, New Zealand, and Japan; 7–14 days to South America and South Africa.
  • Batch-Specific Certificate of Analysis (CoA): Every order includes a detailed CoA with chromatograms, retention times, and purity percentage. Full analytical data available upon request prior to purchase.
  • Flexible Quantity Options: Available in 10, 20, 50, 100, 250, or 500 pellet quantities to suit studies of any scale.

Product Specifications

Property Value
Active Ingredient IDRA-21 – 7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide
IUPAC Name 7-chloro-3-methyl-3,4-dihydro-2H-1λ⁶,2,4-benzothiadiazine-1,1-dione
Compound Class Ampakine; AMPA receptor positive allosteric modulator
Pellet Count Options 10, 20, 50, 100, 250, or 500 pellets per sealed pouch
Dosage per Pellet 10mg ± 3% (content uniformity tested)
Purity (HPLC) >97.0%
Inactive Ingredients Microcrystalline cellulose, lactose, magnesium stearate, colloidal silicon dioxide, pharmaceutical excipients
Heavy Metals <20 ppm
Loss on Drying <0.5%
Pellet Diameter 6 mm ± 0.2 mm
Hardness (Crushing Strength) 5–7 kP

Applications & Usage

IDRA-21 10MG Pellets are strictly intended for forensic, analytical, and in-vitro research applications only. Typical laboratory uses include:

  • AMPA Receptor Electrophysiology: Investigate IDRA-21’s effects on AMPA receptor-mediated excitatory postsynaptic currents (EPSCs) using patch-clamp or two-electrode voltage clamp (TEVC) techniques in brain slice preparations or transfected cell lines (e.g., HEK-293 expressing GluA1-4 subunits).
  • Synaptic Plasticity & Long-Term Potentiation (LTP) Studies: Evaluate IDRA-21’s ability to enhance LTP in hippocampal slices—a cellular correlate of learning and memory. Measure field excitatory postsynaptic potentials (fEPSPs) at Schaffer collateral-CA1 synapses.
  • Cognitive Enhancement Research: In approved IACUC protocols, study IDRA-21’s effects on learning and memory using behavioral paradigms such as the Morris water maze, novel object recognition, radial arm maze, or passive avoidance tests.
  • Analytical Method Development & Validation: Employ as a certified reference standard for LC-MS/MS, GC-MS, or HPLC-DAD method development in pharmacokinetic studies and forensic toxicology.
  • Metabolic Stability Profiling: Evaluate phase I and phase II metabolism using human liver microsomes (HLM), recombinant CYP450 isoforms, or hepatocyte models. Identify major metabolites via high-resolution mass spectrometry.
  • Receptor Binding & Selectivity Studies: Assess IDRA-21’s selectivity for AMPA receptors versus kainate and NMDA receptors using radioligand binding assays.

Researchers are strongly encouraged to follow institutional chemical hygiene plans and consult peer-reviewed literature for comparative pharmacological data. This product is not for in-vivo administration in vertebrate animals without explicit IACUC approval specifically citing its use as a research chemical.

Purity & Testing

At RChems EU, we understand that research reproducibility begins with compound integrity. Every batch of IDRA-21 10MG pellets undergoes a comprehensive analytical workflow before release:

  1. High-Performance Liquid Chromatography (HPLC-DAD): Quantifies purity against a certified reference standard. Acceptance criterion: >97.0% main peak area. All significant impurities are reported with retention times.
  2. Liquid Chromatography-Mass Spectrometry (LC-MS): Confirms molecular ion [M+H]⁺ at m/z 233.0 and characteristic fragmentation pattern. Rules out isobaric contaminants and synthetic byproducts.
  3. Nuclear Magnetic Resonance (¹H and ¹³C NMR): Unambiguously confirms structural identity, including the benzothiadiazine core and the 3-methyl substitution. Verifies absence of unexpected synthetic intermediates.
  4. Karl Fischer Coulometry: Ensures moisture content below 0.5%, critical for long-term pellet stability.
  5. Content Uniformity Testing: Random sampling of pellets from each batch ensures each pellet contains 10mg ± 10% of active ingredient.
  6. Residual Solvent Analysis (GC-FID): Quantifies residual organic solvents from synthesis per ICH Q3C guidelines.

Only batches that pass all six checkpoints are released for distribution. This rigorous approach means when you buy IDRA-21 for research from RChems EU, you eliminate batch-to-batch variability—a primary cause of non-reproducible results in synaptic plasticity and cognitive research.

Safety & Handling Guidelines

WARNING: For research use only. Not for human or animal consumption, therapeutic application, veterinary use, or any form of in-vivo administration outside approved controlled substance protocols.

  • Personal Protective Equipment (PPE): Nitrile gloves, laboratory coat, and chemical splash goggles mandatory when handling pellets or any dissolved solutions.
  • Ventilation: All manipulations should be performed inside a certified chemical fume hood. Avoid crushing pellets or generating airborne particulates.
  • First Aid – Skin Contact: Wash immediately with copious soap and water for at least 15 minutes. Remove contaminated clothing. Seek medical evaluation if irritation develops.
  • First Aid – Eye Contact: Rinse cautiously with water for several minutes. Remove contact lenses if present. Continue rinsing for at least 15 minutes. Seek immediate medical attention.
  • First Aid – Inhalation: Move to fresh air immediately. Administer oxygen if breathing difficulty occurs. Seek immediate medical attention.
  • First Aid – Accidental Ingestion: Do not induce vomiting. Rinse mouth with water. Seek immediate emergency medical care and provide this Safety Data Sheet (SDS) to treating physician.
  • Spill Management: Isolate area, restrict access. Wearing PPE, collect pellets mechanically into a sealed hazardous waste container. Decontaminate surfaces with 70% ethanol.
  • Disposal: Comply with all local, state, and federal regulations for research chemicals. Incineration via a licensed hazardous waste vendor is recommended.

Global Shipping & Discreet Delivery

RChems EU prioritizes your privacy, your research continuity, and the integrity of your supply chain. Our shipping protocols are engineered to attract zero unnecessary attention from customs, couriers, or third parties.

  • Plain Outer Packaging: Standard corrugated cardboard boxes or Tyvek padded envelopes. No company logos, no chemical names, no hazard diamonds. Return address is a generic “Fulfillment Department” or “Logistics Center” with no mention of RChems EU.
  • No Chemical Identifiers on Labels: Shipping labels and commercial invoices never list “IDRA-21,” “ampakine,” “benzothiadiazine,” or “research chemical.” Typical customs descriptions: “Laboratory consumables,” “Non-hazardous solid reference material,” or “In vitro diagnostic reagents (non-human).”
  • Vacuum-Sealed & Tamper-Evident: Each pellet pouch is heat-sealed in food-grade mylar, then vacuum-sealed a second time in an opaque outer pouch. Eliminates moisture ingress and evidence of tampering.
  • Worldwide Coverage: We ship to all 50 US states, Canada, United Kingdom, EU Schengen zone, Switzerland, Norway, Australia, New Zealand, Japan, South Korea, and South Africa.
  • Real-Time Tracking: DHL Express, FedEx Priority, or UPS Worldwide tracking number provided within 24 hours of dispatch. All shipments are insured for full commercial value.

Shipping Tiers:
| Service Level | Transit Time | Cost | Features |
| :— | :— | :— | :— |
| Standard International Airmail | 10–20 business days | Free on orders >$250 | Tracking in select countries |
| Express Courier (DHL/FedEx/UPS) | 3–7 business days | Calculated at checkout | Insured, signature required, real-time GPS tracking |

Why Choose RChems EU?

  • Verified High Purity: Independent batch testing via HPLC, LC-MS, and NMR. Every CoA includes raw chromatograms.
  • Stealth Packaging Industry Standard: Thousands of successful deliveries worldwide. Zero customs seizures directly attributable to packaging failure.
  • Fast Fulfillment: Orders placed before 2 PM EST (Monday–Friday) ship same business day. Weekend orders ship Monday.
  • Scientific Support Team: Available 6 days/week to answer solubility, stability, and analytical method questions.
  • Flexible Quantities: Choose from 10, 20, 50, 100, 250, or 500 pellets to match your research scale.
  • Ethical Compliance: We require institutional affiliation verification for all research product purchases.

IMPORTANT – READ CAREFULLY BEFORE ORDERING:

IDRA-21 is a research chemical belonging to the ampakine class. Its legal status varies by jurisdiction. In most countries, IDRA-21 is not a controlled substance but may be regulated as a research chemical or prescription-only medicine. It is not approved by the FDA, EMA, or any other regulatory agency for human use.

RChems EU sells IDRA-21 10MG Pellets strictly as a research chemical for in-vitro laboratory use only. This product is not for human consumption, personal use, clinical application, cognitive enhancement outside approved research, or any form of in-vivo administration. No medical, therapeutic, or cognitive-enhancing claims are made or implied for human use.

By purchasing this product, you affirm, warrant, and legally bind yourself to the following:

  • You are at least 18 years of age (21 years in certain jurisdictions).
  • You are a qualified researcher affiliated with a recognized academic institution, pharmaceutical company, or research laboratory.
  • You possess any required licenses or import authorizations for this compound in your jurisdiction.
  • You will use this product exclusively for legitimate scientific research purposes.
  • You will not attempt to consume, ingest, or otherwise introduce this product into a living human or animal.

RChems EU reserves the right to refuse any order at its sole discretion, including orders from residential addresses. No refunds for customs seizures where buyer failed to verify import legality.

FAQ Section

Q1: What is IDRA-21 10MG used for in research?
A: IDRA-21 is an ampakine—a positive allosteric modulator (PAM) of AMPA-type glutamate receptors. Typical research applications include electrophysiological studies (patch-clamp recordings of AMPA receptor-mediated currents), synaptic plasticity and long-term potentiation (LTP) research in hippocampal slices, cognitive enhancement studies in approved animal models (Morris water maze, novel object recognition), analytical method development for pharmacokinetic studies, and metabolic stability profiling using human liver microsomes. It is not for human consumption.

Q2: Is IDRA-21 legal to buy for research?
A: Legality varies by jurisdiction. In the USA and most European countries, IDRA-21 is not a controlled substance but may be regulated as a research chemical. It is not FDA-approved for human use. You are solely responsible for verifying your local laws before ordering. RChems EU requires institutional affiliation verification and does not sell to individuals in prohibited jurisdictions. Contact our compliance team for a jurisdiction-specific assessment.

Q3: How discreet is your shipping packaging?
A: Extremely discreet. The outer package is a plain, unmarked box with no branding, no chemical names, and no hazard warnings. The return address is a generic “Fulfillment Department.” Customs declarations list generic terms like “laboratory consumables” or “inert solid reference material.” Inside, pellets are sealed in an opaque, vacuum-sealed mylar pouch with no external labeling. We maintain a 99.7% successful delivery rate to research institutions globally.

Q4: What is the exact purity level, and how is it tested?
A: Purity is greater than 97% as determined by HPLC-DAD. Each batch’s Certificate of Analysis includes the exact purity percentage, representative chromatograms, LC-MS confirmation, and residual solvent analysis. We use orthogonal analytical methods (HPLC + LC-MS + NMR) to confirm identity and purity. Full CoAs are available upon request.

Q5: How should I store IDRA-21 10MG pellets after opening?
A: Store in the original sealed mylar pouch or transfer to a tight, amber glass vial with a desiccant packet. Keep at controlled room temperature (15–25°C / 59–77°F), away from direct sunlight, heat, and humidity exceeding 60%. Do not refrigerate or freeze. Under proper storage, chemical stability remains high for 24 months. Always allow the sealed container to reach room temperature before opening.

Q6: What quantity options are available?
A: IDRA-21 10MG Pellets are available in six quantities: 10, 20, 50, 100, 250, or 500 pellets. This flexibility allows researchers to order appropriate amounts for pilot studies, full-scale experiments, or long-term research programs. Volume discounts apply to larger quantities.

Q7: Can I receive a Certificate of Analysis before ordering?
A: Absolutely. Contact our scientific support team with the product name (IDRA-21 10MG Pellets), your institutional affiliation, and intended research application. We will provide a representative CoA from the current production batch, including HPLC purity percentage, impurity profile, and chromatograms. Full, lot-specific CoAs are included inside every shipment.

Q8: What is the mechanism of action of IDRA-21?
A: IDRA-21 is a positive allosteric modulator (PAM) of AMPA-type glutamate receptors. Unlike competitive agonists that bind to the active site, IDRA-21 binds to a modulatory site on the receptor, slowing receptor deactivation and desensitization. This prolongs the duration of excitatory postsynaptic currents (EPSCs), enhances synaptic transmission, and facilitates long-term potentiation (LTP)—a cellular correlate of learning and memory. This mechanism underlies its research applications in cognitive enhancement and synaptic plasticity.

Q9: What solvents are recommended for dissolving IDRA-21 pellets?
A: IDRA-21 is soluble in DMSO (>30 mg/mL) and ethanol (>20 mg/mL). For electrophysiology or receptor binding assays, prepare a stock solution in DMSO (e.g., 10–20 mM), then dilute in assay buffer (final DMSO concentration <0.1%). For analytical standards, use methanol or acetonitrile. Aqueous solubility is limited. Avoid prolonged exposure to light and heat after dissolution.

Q10: Are the pellets scored or designed for division?
A: No. The pellets are manufactured as homogeneous, whole-unit analytical standards. They are not scored and are not designed for splitting. Crushing or cutting pellets will compromise dose uniformity. For studies requiring multiple concentration points, dissolve entire pellets in solvent and perform serial volumetric dilutions.

Q11: Can I request a custom dosage or larger quantity?
A: Yes. For research institutions requiring custom dosing formats (e.g., 5mg, 15mg, 20mg, 25mg pellets) or larger batch quantities (1000+ pellets), contact our institutional sales team. We offer custom synthesis and custom pellet compression with the same high-purity standards. Minimum order quantities vary.

Ready to advance your AMPA receptor and cognitive research? Order IDRA-21 10MG Pellets today from RChems EU – where purity, precision, and discretion define every shipment.

For bulk institutional inquiries, standing purchase orders, or custom dosing formats, please contact our scientific sales team. Academic discounts available for verified institutions.